Sudan ebolavirus


The species Sudan ebolavirus is a virological taxon included in the genus Ebolavirus, family Filoviridae, order Mononegavirales. The species has a single virus member, Sudan virus. The members of the species are called Sudan ebolaviruses.

Nomenclature

The name Sudan ebolavirus is derived from Sudan and the taxonomic suffix ebolavirus.
The species was introduced in 1998 as Sudan Ebola virus. In 2002, the name was changed to Sudan ebolavirus.
A virus of the genus Ebolavirus is a member of the species Sudan ebolavirus if:
Sudan virus is one of six known viruses within the genus Ebolavirus and one of the four that causes Ebola virus disease in humans and other primates; it is the sole member of the species Sudan ebolavirus. SUDV is a Select agent, World Health Organization Risk Group 4 Pathogen, National Institutes of Health/National Institute of Allergy and Infectious Diseases Category A Priority Pathogen, Centers for Disease Control and Prevention Category A Bioterrorism Agent, and listed as a Biological Agent for Export Control by the Australia Group.
The first known outbreak of EVD occurred due to Sudan virus in South Sudan between June and November 1976, infecting 284 people and killing 151, with the first identifiable case on 27 June 1976.

Use of term

Sudan virus was first described in 1977. It is the single member of the species Sudan ebolavirus, which is included into the genus Ebolavirus, family Filoviridae, order Mononegavirales. The name Sudan virus is derived from South Sudan and the taxonomic suffix virus. According to the rules for taxon naming established by the International Committee on Taxonomy of Viruses, the name Sudan virus is always to be capitalized, but is never italicized, and may be abbreviated.

Previous designations

Sudan virus was first introduced as a new "strain" of Ebola virus in 1977. Sudan virus was described as "Ebola haemorrhagic fever" in a 1978 WHO report describing the 1976 Sudan outbreak. In 2000, it received the designation Sudan Ebola virus and in 2002 the name was changed to Sudan ebolavirus. Previous abbreviations for the virus were EBOV-S and most recently SEBOV. The virus received its final designation in 2010, when it was renamed Sudan virus.

Virus inclusion criteria

A virus of the species Sudan ebolavirus is a Sudan virus if it has the properties of Sudan ebolaviruses and if its genome diverges from that of the prototype Sudan virus, Sudan virus variant Boniface, by ≤10% at the nucleotide level.

Disease

SUDV is one of four ebolaviruses that causes Ebola virus disease in humans. EVD due to SUDV infection cannot be differentiated from EVD caused by other ebolaviruses by clinical observation alone, which is why the clinical presentation and pathology of infections by all ebolaviruses is presented together on a separate page. In the past, SUDV has caused the following EVD outbreaks:
YearGeographic locationHuman cases/deaths
1976Juba, Maridi, Nzara, and Tembura, South Sudan284/151
1979Nzara, South Sudan34/22
2000–2001Gulu, Mbarara, and Masindi Districts, Uganda425/224
2004Yambio County, South Sudan17/7
2011Luweero District, Uganda1/1
2014Equateur, Congo0/1 * two strains reported, one Sudan and one Sudan/Zaire Hybrid to 24/08/2014

Research

The Public Health Agency of Canada has a candidate rVSV vaccine for Sudan ebolavirus. Merck was developing it, but discontinued development.

Ecology

The ecology of SUDV is currently unclear and no reservoir host has yet been identified. Therefore, it remains unclear how SUDV was repeatedly introduced into human populations. Bats are suspected to harbor the virus because infectious Marburg virus, a distantly related filovirus, has been isolated from bats, and because traces of the more closely related Ebola virus were found in bats as well.

Molecular biology

SUDV is basically uncharacterized on a molecular level. However, its genomic sequence, and with it the genomic organization and the conservation of individual open reading frames, is similar to that of the other four known ebolaviruses. It is therefore currently assumed that the knowledge obtained for EBOV can be extrapolated to SUDV and that all SUDV proteins behave analogous to those of EBOV.